SpeechNutrients Initiates Focus Group for Children with Speech Challenges

SpeechNutrients, a division of NourishLife, announces the start of a Focus Group with their PharmaOmega speakTM product. A group of about 80 children with speech challenges has been selected to participate in the 3 month event.

Lake Forest, IL (Vocus) September 24, 2008 -- SpeechNutrients announced today the commencement of a Focus Group for PharmaOmega speakTM (http://www.speechnutrients.com), their patented omega-3/antioxidant cocktail. About 80 children and young adults will receive the complimentary PharmaOmega speakTM for a 3 month period.

Families of children who face speech difficulties were invited to participate in the PharmaOmega speakTM Focus Group. The response was overwhelming, and unfortunately many applicants had to be declined. Approximately 80 participants from the USA, Canada, and Europe will record their observations and experiences and report both positive and negative results.

PharmaOmega speakTM is a nutritional product designed to support normal speech development and maintenance. The patented formulation provides seven nutrients in the precise dose and ratio shown to be effective in 2 pre-measured, pleasant tasting, hypo-allergenic capsules. Before the development of PharmaOmega speakTM, this combination of nutrients had to be purchased separately in 12 capsules and tablets and at a much higher cost. Information is available at www.SpeechNutrients.com.

Research behind the formula has been published at the Proceedings of the Annual Meeting of the Pediatric Academy Societies in 2007 and 2008. (See the abstract www.SpeechTrial.com/research_publications.aspx)

Mark Nottoli, co-founder of NourishLife states, "The anecdotal evidence reported by a large number of parents is encouraging. The patented formula in PharmaOmega speakTM has been developed with great attention to the latest science and research. We cannot expect this formulation to help every child, but a significant percentage are experiencing positive results. With our precise patented formulation and the convenient 2-capsule delivery form, we expect even better outcomes."

According to Gretchen K. Vannice, MS, RD, Manager of Scientific Affairs at NourishLife, "We are pleased to have the opportunity to provide this special formula to families in the Focus Group. We look forward to what we will learn and to providing PharmaOmega speakTM for the proposed double-blind, placebo-controlled clinical trial."

About NourishLife:

NourishLife www.NourishLife.com intends to contribute to a major improvement in health and wellness by addressing nutritional deficiencies. Founded by nutrition industry veterans, the firm employs expert scientists and nutritionists passionate about health. The PharmaOmega division of NourishLife www.PharmaOmega.com is the premier source of omega-3 information, research and news.

The firm was awarded an exclusive license to a patented nutritional formulation designed to support normal speech development. Preliminary anecdotal evidence shows promise with reports of benefits that include improved speech, imitation, coordination, eye contact, behavior and sensory issues. NourishLife formed a partnership with Croda, the maker’s of Lorenzo's Oil, for the pharmaceutical grade omega 3 used in their "speak" product. More information can be found at www.SpeechNutrients.com.

NourishLife is a privately held business located outside of Chicago.

Press Contact:

Mark Nottoli, NourishLife LLC, 250 E. Deerpath Road, Lake Forest, IL 60045 USA

Tel: 847-582-1313

Email: mark @ SpeechNutrients.com

###


Contact Information
Mark Nottoli
NourishLife
http://www.SpeechNutrients.com
847-582-1313

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy